MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-BR-26-0044613
Laxor Pharma Private Limited
Laxor Pharma Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.57 Cr
▼ 1% YoY
Net profit · FY 2025
₹6.15 Lakh
Net margin 1.7%
EBITDA · FY 2025
₹15.2 Lakh
EBITDA margin 4.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
20 yrs
Est. 2006
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Laxor Pharma Private Limited
Data last updated:
Laxor Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 January 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2006PTC047576. Its GSTIN is 10AACCL1736F1Z5 (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Md Yusuf and Imtiyaz Ahmad.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 24 Venus Atlantis Corporate Park, Ahmedabad, Gujarat.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.57 Cr, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹6.15 Lakh (net margin 1.7%) and EBITDA of ₹15.2 Lakh (EBITDA margin 4.3%). Revenue has declined at a compounded annual rate (CAGR) of 3% over three years and 3% over five years.
Court records list 8 cases involving the company, including 2 filed by the company and 6 filed against it; 1 case is pending.
Laxor Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0044613). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Laxor Pharma Private Limited
CIN U24230GJ2006PTC047576
Registration Number 047576
Incorporation Date 24 January 2006
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-BR-26-0044613
Key People
Md Yusuf Director Imtiyaz Ahmad Director Recognitions & Rankings of Laxor Pharma
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressOffice No. 24 Venus Atlantis Corporate Park Ground Floor Opp. Safal Pegasus Prahla, D Nagar, Ahmedabad, Gujarat, India – 380054
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Laxor Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Laxor Pharma Private Limited
The main business activity of Laxor Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Laxor Pharma Private Limited FY 2025 filings available
Laxor Pharma Private Limited reported revenue of ₹3.57 Cr (down 1% YoY) for FY 2025.
Revenue · FY 2025
₹3.57 Cr ▼ 1%
Net profit · FY 2025
₹6.15 Lakh margin 1.7%
EBITDA · FY 2025
₹15.2 Lakh margin 4.3%
Compounded Annual Growth Rate (CAGR) of Laxor Pharma Private Limited
Revenue CAGR growth
1 year
▼ 1%
3 years · compounded
▲ 3%
5 years · compounded
▼ 3%
EBITDA CAGR growth
1 year
▼ 26%
3 years · compounded
▼ 12%
5 years · compounded
▼ 17%
Revenue has declined at a compounded annual rate (CAGR) of 3% over five years, including a 1% fall in the latest year. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Laxor Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹15.2 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.15 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Laxor Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Laxor Pharma are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Laxor Pharma Private Limited
Laxor Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Md Yusuf | Director | 21 Dec 2011 | 14 Years 9 Months | Current |
| Imtiyaz Ahmad | Director | 26 Jan 2006 | 20 Years 8 Months | Current |
Peer Comparison of Laxor Pharma Private Limited
Laxor Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Excellent Formulations Private Limited | ₹3.57 Cr (FY 2024) | •••• | •••• | 86.0% | •••• | New Delhi, Delhi, India |
| Curega Healthcare Private Limited | ₹3.57 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Pune, Maharashtra, India |
| Dhanshah Healthcare Private Limited | ₹3.57 Cr (FY 2025) | •••• | •••• | 14337.0% | •••• | Dholpur, Rajasthan, India |
| Genext Healthcare Private Limited | ₹3.57 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | Guwahati, Assam, India |
| Shirr Pharmaceuticals Private Limited | ₹3.57 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Thiruvananthapuram, Kerala, India |
| Laxor Pharma Private Limited this company | ₹3.57 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Ahmedabad, Gujarat, India |
| Aayush Medication Private Limited | ₹3.55 Cr (FY 2024) | •••• | •••• | 4.0% | •••• | Vapi, Gujarat, India |
| Lohitha Chemtek Private Limited | ₹3.55 Cr (FY 2025) | •••• | •••• | 212.0% | •••• | Hyderabad, Telangana, India |
| Plus India Formulation Private Limited | ₹3.55 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Hyderabad, Telangana, India |
| Cuidado Medico Private Limited | ₹3.54 Cr (FY 2025) | •••• | •••• | 46.0% | •••• | Ahmedabad, Gujarat, India |
| Grefith Industries Private Limited | ₹3.53 Cr (FY 2025) | •••• | •••• | 17.0% | •••• | Chandigarh, India |
Peers are the five companies nearest above and the five nearest below Laxor Pharma by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Laxor Pharma Private Limited
Laxor Pharma Private Limited is audited by SACHIN AGRAWAL & GUPTA for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SACHIN AGRAWAL & GUPTA | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Laxor Pharma Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Laxor Pharma Private Limited
Laxor Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Laxor Pharma Private Limited
Laxor Pharma Private Limited has 8 court cases on record: 2 filed by Laxor Pharma, 6 filed against it. 1 case is pending and 7 are disposed. Status as checked between 29 Sep 2026 and 04 Oct 2026.
Total cases
8
Filed by the company
2
Filed against the company
6
Pending
1
Disposed
7
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 8 | 6 | 1 |
Cases on record (5 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Poonawalla Fincorp Limited | Pending |
| District court, Calcutta, West Bengal | Civil suit | Filed against the company by Poonawalla Fincorp Limited | Disposed |
| District court, Shimla, Himachal Pradesh | Civil miscellaneous application | Filed against the company by an individual | Disposed |
| District court, Shimla, Himachal Pradesh | Arbitration matter | Filed against the company by an individual | Disposed |
| District court, Shimla, Himachal Pradesh | Civil miscellaneous application | Filed by the company against an individual | Disposed |
Premium access
Full case history
All 8 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Laxor Pharma Private Limited
Employment history and EPFO contributions of people linked to Laxor Pharma.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Laxor Pharma Private Limited
Laxor Pharma Private Limited has 6 board changes on record since 2006: 4 appointments and 2 cessations. The latest: Mohd Firoz Alam ceased to be Director on 22 Dec 2011.
AGM
Laxor Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Laxor Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Mohd Firoz Alam ceased to be Director.
Ceased
Tauqeer Ahmad ceased to be Director.
Appointed
Md Yusuf was appointed as Director.
Appointed
Imtiyaz Ahmad was appointed as Director.
Appointed
Tauqeer Ahmad was appointed as Director.
Appointed
Mohd Firoz Alam was appointed as Director.
Incorporation
24 Jan 2006
Laxor Pharma Private Limited was registered on 24 Jan 2006 with Roc Ahmedabad & aged 20 years 8 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Laxor Pharma Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Laxor Pharma Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Laxor Pharma Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Laxor Pharma Private Limited
Laxor Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AACCL1736F1Z5 | Bihar | Active | 01 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Laxor Pharma Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Laxor Pharma Private Limited
Laxor Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 January 2006 (20+ years old) and is registered under CIN U24230GJ2006PTC047576.
Laxor Pharma reported revenue of ₹3.57 Cr for FY 2025 (down 1% YoY).
Laxor Pharma has 2 current directors:
- Md Yusuf - Director
- Imtiyaz Ahmad - Director
Laxor Pharma reported a net profit of ₹6.15 Lakh (net margin 1.7%) and EBITDA of ₹15.2 Lakh (EBITDA margin 4.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Laxor Pharma is 3% over three years and -3% over five years. In the latest year (FY 2025) revenue fell 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Laxor Pharma is 10AACCL1736F1Z5, registered in Bihar.
The CIN (Corporate Identification Number) of Laxor Pharma is U24230GJ2006PTC047576. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Laxor Pharma has 8 court cases on record: 2 filed by the company and 6 filed against it. 1 is pending.
Laxor Pharma was incorporated on 24 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Laxor Pharma by revenue are Excellent Formulations Private Limited, Curega Healthcare Private Limited, Dhanshah Healthcare Private Limited, Genext Healthcare Private Limited, Shirr Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations).
Mohd Firoz Alam ceased to be Director on 22 Dec 2011. Tauqeer Ahmad ceased to be Director on 22 Dec 2011. Md Yusuf was appointed as Director on 21 Dec 2011. Laxor Pharma has 6 board changes on record in total.